NOWDx Focuses on On-Site Diagnosis

Just inside the front door of NOWDiagnostics is a dog bed with a chew toy that is roughly the size of an elephant femur. The owner of the chew toy bounds up to visitors: Annie, an overtly cheerful 7-month-old Irish wolfhound who belongs to NOWDiagnostics CEO Kevin Clark. Annie, after being petted partially in self-defense, soon lopes off through the office complex to make her rounds at the Springdale facility. Don’t mistake the casualness of the greeting for a lack of seriousness at NOWDiagnostics. Clark and his staff of mostly Ph.D.-credentialed researchers are doing serious and potentially lifesaving work. “I personally think this can save the health care industry billions of dollars,” Clark said. “It empowers people to make the right decision sooner, getting results faster and getting treatment started faster.” NOWDiagnostics manufactures one-step medical diagnosis devices that can generate lab-quality results in minutes. Clark said the company has 36 products in its trademarked ADEXUSDx line in some stage of development for ailments ranging from heart attacks to sexually transmitted diseases. In August, the company received FDA approval for its ADEXUSDx pregnancy test for use in clinics and hospitals in the United States. NOWDiagnostics has five other tests — two for cardiac markers and three for toxicology levels — that are approved for use in Europe as well. The pregnancy test works with a drop of blood rather than urine and can...
Source: Arkansas Business - Health Care - Category: American Health Source Type: news